Vitestro: $70 Million Raised To Advance Autonomous Robotic Blood Collection Technology
By Amit Chowdhry ● Today at 3:57 PM
Vitestro, a Netherlands-based medical robotics company developing autonomous blood-drawing technology, has raised $70 million in an oversubscribed Series B financing round to accelerate development of its robotic phlebotomy platform and expand commercial readiness. The round drew participation from several new strategic healthcare investors including Labcorp Venture Fund, Mayo Clinic and Sutter Health. Additional new financial investors included InterVest, MGFO, PGGM, Puma Venture Capital and ROM Utrecht. Existing investors Invest-NL, the EIC Fund, Fred Moll, NYBC Ventures and Sonder Capital also participated in the financing.